Tervetuloa
Onko Sinulla jo Campus Sanofi tili? Rekisteröidy tai kirjaudu sisään ja lue lisää Sanofin tuotteista ja palveluista.
Artikkelit
Type 1 Diabetes Came as a Surprise in Adulthood – Sara's Story
A little over a year ago, Sara, 34, received life-changing news: She had been diagnosed with type 1 diabetes. A condition often associated with children and adolescents had suddenly appeared in adulthood. The diagnosis meant adjusting to a new daily routine and undergoing significant mental adaptation. It also brought insights and a deeper understanding of herself. Living in Helsinki, Sara openly shares how her life has changed and how even a little humor can help during challenging times.
Future Plans Changed in an Instant – Life with Diabetes
When Kris from Oulu heard two years ago that her 16-year-old son Allan had been diagnosed with type 1 diabetes, her world stopped for a moment. Allan, who lives in Rovaniemi with his father, had been symptomatic for a while, but the family hadn't connected the symptoms to a serious illness. The diagnosis was a shock that permanently changed the family's daily life – and Allan's future dream.
BRIGHT publication
The Bright study demonstrated similar efficacy and safety of Toujeo® (Glargine 300 U/ml) compared to degludec 100 U/ml in type 2 diabetes patients who had not previously received basal insulin1.
DELIVER-G: Real-world analysis in insulin-naïve adults with T2DM on GLP-1 RA ± OAD(s), intensifying their therapy by starting basal insulin and discontinuing GLP-1 RA, or adding basal insulin to ongoing GLP-1 RA, or initiating a FRC product and discontinuing current GLP-1 RA†1
DELIVER-G: Real-world analysis in insulin-naïve adults with T2DM on GLP-1 RA ± OAD(s), intensifying their therapy by starting basal insulin and discontinuing GLP-1 RA, or adding basal insulin to ongoing GLP-1 RA, or initiating a FRC product and discontinuing current GLP-1 RA†1
The RESTORE-G Real World Evidence Study
RESTORE-G: Real-world analysis in insulin-naïve adults with T2D on GLP-1 RA ± OAD(s), intensifying their therapy by starting basal insulin and discontinuing GLP-1 RA, or adding basal insulin to ongoing GLP-1 RA, or initiating a FRC product and discontinuing current GLP-1 RA†2
Koulutus
Transforming Atopic Dermatitis Care: The Impact of Early Treatment – A DermTalks Webinar
Polyp Gossip Overview
Polyp Gossip is a video podcast dedicated to exploring Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Hosted by two globally recognized rhinologists. The show delves into trending topics, latest advancements, and patient experiences. Each episode features esteemed guests, including experts and patients, offering valuable insights into the evolving world of CRSwNP.
Polyp Gossip Episode 3: Living with CRSwNP: Daily Challenges and Solutions
In this episode of Polyp Gossip, we dive into the real-life experiences of patients living with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), exploring how the condition impacts their daily routines, relationships, and overall well-being. Our guests share their journeys, shedding light on the emotional and physical toll of the condition.
Polyp Gossip Episode 4: To Cut Or Not To Cut
In this episode we explore the critical decision of whether surgery is the right choice for CRSwNP patients. Leading experts discuss the factors influencing surgical vs. medical management, patient considerations, and the latest advancements in treatment. Tune in for an in-depth look at this big decision in CRSwNP care!
The VESTIGE trial
Evaluating the effect of dupilumab on type 2 airway inflammation and mucus plugging in patients with uncontrolled moderate-to-severe asthma.1